Objective To determine whether receptors for B lymphocyte stimulator (BLyS) are altered on
B cells of patients with systemic lupus erythematosus (SLE). Methods Total available …

Background: The cytokine B cell-activating factor of the TNF family (BAFF) is involved in the
pathogenesis of autoimmune diseases. Objective: To access changes in serum protein and …

The B-cell survival factors APRIL and BLyS are important for B-cell maturation and activation
and contribute to human autoimmune diseases. Interference with B-cell function by targeting …

The objective of this study was to investigate the interaction between levels of BAFF (B-cell
activation factor of the tumour necrosis factor [TNF] family) and APRIL (a proliferation …

Objective To determine whether serum BAFF levels correlate with relapse or remission in
patients with systemic lupus erythematosus (SLE) following B cell depletion therapy (BCDT) …

Background Systemic lupus erythematosus (SLE) is a systemic autoimmune disease, which
exhibits multiple B cell abnormalities including expanded populations of memory B cells and …

B-cell-activating factor of the tumour-necrosis-factor family (BAFF) enhances B-cell survival—
a function that is indispensable for B-cell maturation—and has a role in enhancing immune …

Constitutive overexpression of B cell-activating factor belonging to the TNF family (BAFF)
promotes development of systemic lupus erythematosus (SLE), and treatment of SLE mice …

B cell-activating factor belonging to the TNF family (BAFF) exerts its pathogenic role in
supporting the survival and proliferation of B cells, regulating class switch recombination as …

Overexpression of B-lymphocyte activating factor (BAFF) results in arthritis,
glomerulonephritis and autoantibody formation in mice, but its role in human autoimmune …